Evidence map›Paper›PMID 26983959›Full record

SynthesisDiabetes2016

Expression-Based Genome-Wide Association Study Links Vitamin D-Binding Protein With Autoantigenicity in Type 1 Diabetes.

Keiichi Kodama, Zhiyuan Zhao, Kyoko Toda, Linda Yip, Rebecca Fuhlbrigge, Dongmei Miao, C Garrison Fathman, Satoru Yamada, Atul J Butte, Liping Yu

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Vitamin D and Beta Cells in Type 1 Diabetes: A Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Persistent organic pollutants and β-cell toxicity: a comprehensive review.American journal of physiology. Endocrinology and metabolism · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Keiichi KodamaInstitute for Computational Health Sciences, Department of Pediatrics, University of California, San Francisco, San Francisco, CA keiichi.kodama@ucsf.edu.
Zhiyuan ZhaoBarbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO.
Kyoko TodaBiomedical Research Center, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan.
Linda YipDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Rebecca FuhlbriggeDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Dongmei MiaoBarbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO.
C Garrison FathmanDivision of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
Satoru YamadaDiabetes Center, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan.
Atul J ButteInstitute for Computational Health Sciences, Department of Pediatrics, University of California, San Francisco, San Francisco, CA.
Liping YuBarbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, CO liping.yu@ucdenver.edu.
Stanford University · USUniversity of Colorado Denver · USUniversity of California, San Francisco · USKitasato Institute Hospital · JPKitasato University · JP

Funding

Multiple Autoantigens/Multiple Epitopes of Type 1DMR01DK032083 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI MICHELS, AARON W · 1986 to 2025
$6.9M
Repositioning drugs for the treatment of small cell lung cancerR01GM079719 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BUTTE, ATUL J · 2006 to 2015
$4.4M
Integrating Microarray and Proteomic Data by Ontology-based AnnotationR01LM009719 · NLM · STANFORD UNIVERSITY · PI BUTTE, ATUL J · 2008 to 2011
$1.1M
NIDDK NIH HHS R01 DK032083NIGMS NIH HHS R01 GM079719NLM NIH HHS R01 LM009719
6 · The paper itself

Abstract

Type 1 diabetes (T1D) is caused by autoreactive T cells that recognize pancreatic islet antigens and destroy insulin-producing β-cells. This attack results from a breakdown in tolerance for self-antigens, which is controlled by ectopic antigen expression in the thymus and pancreatic lymph nodes (PLNs). The autoantigens known to be involved include a set of islet proteins, such as insulin, GAD65, IA-2, and ZnT8. In an attempt to identify additional antigenic proteins, we performed an expression-based genome-wide association study using microarray data from 118 arrays of the thymus and PLNs of T1D mice. We ranked all 16,089 protein-coding genes by the likelihood of finding repeated differential expression and the degree of tissue specificity for pancreatic islets. The top autoantigen candidate was vitamin D-binding protein (VDBP). T-cell proliferation assays showed stronger T-cell reactivity to VDBP compared with control stimulations. Higher levels and frequencies of serum anti-VDBP autoantibodies (VDBP-Abs) were identified in patients with T1D (n = 331) than in healthy control subjects (n = 77). Serum vitamin D levels were negatively correlated with VDBP-Ab levels in patients in whom T1D developed during the winter. Immunohistochemical localization revealed that VDBP was specifically expressed in α-cells of pancreatic islets. We propose that VDBP could be an autoantigen in T1D.

Indexed as

AutoimmunityGene Expression Regulation, DevelopmentalAdolescentAnimalsAutoantigensAutoimmune DiseasesCase-Control StudiesCells, CulturedChildChild, PreschoolColoradoDiabetes Mellitus, Type 1FemaleGenome-Wide Association StudyGlucagon-Secreting CellsHumans25-hydroxyvitamin DAutoantigensVitamin DVitamin D-Binding Protein

Identifiers

PMID26983959
PMCPMC4839207
OpenAlexW2302488581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.